Star Scientific to Pursue Tobacco-Related Drugs

Source from:  tobaccoreporter.com Tuesday, June 26, 2007 06/28/2007

Star Scientific says it is reorganizing and may spin-off its tobacco-based operations, reports Techjournal South. The company has incorporated a new entity to pursue tobacco-related drugs to treat smokeless tobacco dependence. It will also look at agents in tobacco to treat central nervous system disorders such as Alzheimer's, Parkinson's, schizophrenia and depression. Targacept, an RJR spin-off is also developing drugs to treat neurological diseases with agents similar to nicotine. The company says it will split into two publicly traded units, one focused on tobacco manufacturing and the other on drugs that use a tobacco-based element. Enditem